comprehensive -WSS

comprehensive

author：leisure time 2025-09-30 00:08:52 - browse：738

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for the last day here.

ASCO is more than half done. There is free coffee on the exhibit floor. One booth barista said their team had made 1,400 espressos in a day. Everyone’s perspective is alternating between two verses from Smashing Pumpkins, who are, lest you forget, a Chicago band. “Today is the greatest day I’ve ever known.” Also: “I’ll burn my eyes out before I get out.”

What if sometimes cancer doctors could give less medicine?

Are cancer drugs more likely to be cures? Or could they instead turn cancer into a chronic disease, in which medicines keep tumors in check but patients have to deal with their side effects, both physical and financial, for the rest of their lives.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： New documents shed light on MD Anderson Cancer Institute feud

WSS

NIH study of ME/CFS points to clear biological hallmarks

A new nitrogen execution bill also undermines medical licensing

Why the world’s most expensive drug might be worth the price

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Dario to buy mental health app maker Twill in cash and stock deal

explore

comprehensive

What if sometimes cancer doctors could give less medicine?

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Cancer drug shortages should be causing more outrage

There's no autism epidemic. It's an autism diagnosis epidemic

Hepatitis C has a cure — but many Americans still lack access to it

A solution to the after

Alkermes shareholders re

Supreme Court mifepristone arguments center on docs' right to sue

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

How to save PrEP access — and even expand it

6 phony surgeries that take placebo to the extreme

entertainment

Why the world’s most expensive drug might be worth the price

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Primary care physicians play key roles in Alzheimer's management

STAT readers on older presidents, polypills, Medicare, and more

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Alabama IVF ruling threatens families facing fatal genetic disease

knowledge

Wikipedia

focus

knowledge